Your biological age and cancer risk: the epigenetic connection
You might think your age is simply a number on your driving licence. But your body keeps multiple ages at once. There’s your chronological age — the years since you were born. And then there’s your biological age: how old your cells actually are, measured at the molecular level. The gap between the two can be striking. Some people at 60 have the cellular profile of someone in their 40s. Others at 50 are ageing much faster. And crucially, biological age — not chronological age — is emerging as a meaningful predictor of cancer risk.
This post explores what we know about biological ageing, how to measure it, why it matters for cancer, and what evidence suggests we might do about it.
What is biological age and why should you care
Chronological age is passive. You simply exist for a certain number of years and that’s your age. Biological age is active: it reflects the accumulation of damage and dysfunction across your cells, organs, and systems. At the molecular level, ageing isn’t random; it follows measurable patterns in your DNA.
One of the clearest markers is DNA methylation — a chemical tag that sits on your DNA and influences whether genes are switched on or off. As you age, your methylation patterns change in consistent, predictable ways. By looking at these patterns, scientists can now estimate how “old” your cells are compared with your chronological age. That estimate is your epigenetic age.
The key finding: your epigenetic age is a stronger predictor of disease risk and mortality than your chronological age alone. Studies show that people whose epigenetic age exceeds their chronological age — what researchers call “age acceleration” — face higher risks of cardiovascular disease, cognitive decline, and cancer.
The evidence: epigenetic age and cancer risk
A large prospective cohort study by Dugué and colleagues, published in the International Journal of Cancer in 2017, followed over 3,000 participants without cancer at baseline and tracked their health over several years. They found that individuals with higher epigenetic age acceleration had significantly increased risks of being diagnosed with cancer during follow-up. The effect was independent of chronological age — it was the biological age that predicted risk.
This pattern has since been replicated in several independent cohorts. Research by Chung and colleagues (Epigenetics, 2021) and more recent work by Malyutina et al. (International Journal of Molecular Sciences, 2024) confirms that epigenetic age is a robust marker of cancer risk. Importantly, this is an observational finding — we’re not yet sure about causation, but the association is real and consistent.
Why might epigenetic age influence cancer risk? The mechanisms aren’t fully understood, but the leading ideas include:
Accumulated DNA damage. Epigenetic age reflects years of exposure to oxidative stress, inflammation, and other cellular insults. Cells with higher “age” may have accumulated mutations and epigenetic changes that predispose them to malignancy.
Declining immunity. Ageing is marked by a gradual weakening of immune surveillance. Older cells — and older immune cells in particular — may be less effective at spotting and eliminating precancerous cells.
Loss of cellular repair capacity. DNA methylation patterns are associated with the expression of genes involved in DNA repair. Age-accelerated cells may have compromised repair machinery, leaving mutations uncorrected.
Chronic inflammation. Epigenetic age is closely tied to inflammatory markers. Chronic inflammation is a known cancer risk factor.
Can you slow your epigenetic age? The emerging evidence
This is where it gets genuinely interesting, because for the first time, we have experimental evidence that lifestyle changes can slow or even reverse epigenetic age acceleration.
The landmark trials
A 2021 randomised controlled trial by Fitzgerald and colleagues, published in Aging, studied 43 healthy men aged 50–72 over one year. Half followed a structured intervention combining Mediterranean-style eating, regular exercise, stress reduction (mindfulness), quality sleep, and targeted supplementation (probiotics, omega-3s, vitamin D, zinc). The other half carried on as usual.
The result: the intervention group showed an average 3.23-year reduction in epigenetic age — a reversal of biological ageing. The control group saw no change or slight acceleration. It is worth noting that a correction was published in 2024 (DOI: 10.18632/aging.205700); the headline figure has been verified as holding. This was a small RCT, but the finding was striking.
Fitzgerald’s group then published preliminary data on six women aged 40–55 who followed a similar year-long programme in the Aging journal in 2023. Five of the six showed epigenetic age reduction, with an average reversal of approximately 1.5 years. This is a case series, not an RCT — the evidence is preliminary and should not be treated as confirmed — but the direction is consistent.
Other trials have produced encouraging but varied results. Fiorito et al.’s DAMA study (Aging Cell, 2021) found that a Mediterranean diet intervention slowed epigenetic ageing. Yaskolka Meir et al. (Clinical Epigenetics, 2021) reported that a structured lifestyle intervention reduced epigenetic age in people with metabolic syndrome. Most recently, Villanueva et al. (Aging, 2025) found that a combination intervention including diet, exercise, and stress reduction slowed biological ageing markers.
What do these programmes actually involve?
Dietary pattern. Mediterranean-style or Green-Mediterranean (high in polyphenols, low in red meat and processed foods). The DIRECT PLUS trial (BMC Medicine, 2023) specifically tested a green-Mediterranean pattern — abundant plant foods, legumes, whole grains, olive oil, herbs and spices — and found it associated with approximately 8.9 months’ attenuation of biological age after 18 months.
Regular exercise. Structured, moderate-to-vigorous activity, typically 150+ minutes per week of aerobic activity plus some resistance training. Exercise is consistently associated with slower epigenetic ageing.
Sleep quality. Seven to nine hours per night, with consistent sleep-wake times. Sleep is when cellular repair and epigenetic remodelling happen.
Stress reduction. Mindfulness-based interventions, meditation, or structured stress management. Chronic stress drives age acceleration through inflammatory pathways.
Micronutrient density. Most programmes include targeted supplementation with omega-3s, vitamin D, zinc, and probiotics — though the role of supplements versus whole foods isn’t yet clear from the evidence.
What this means in practice
If you’re interested in slowing your epigenetic age — and by extension, potentially reducing your cancer risk — the good news is that the lifestyle factors involved are ones you probably already know matter: eat well, move regularly, sleep properly, and manage stress. The novel insight is that these changes may work partly through slowing your biological clock.
Start with one or two changes. You don’t need to overhaul everything at once. Pick the area where you have the most room for improvement. If sleep is your weak point, prioritise that. If movement is missing, build in 30 minutes of brisk walking most days. If your diet is highly processed, swap one meal a day for something whole-food-based.
Think in terms of patterns, not perfection. The trials used structured programmes, but they weren’t rigid. The Mediterranean pattern is flexible — it’s about abundance of plants, healthy fats, and whole foods, not calorie counting or restriction.
Be patient. The Fitzgerald trial ran for one year to see meaningful change. Epigenetic age doesn’t shift in weeks. But that also means consistency matters more than intensity. A moderate, sustainable change you stick with will outpace a dramatic overhaul you abandon after a month.
Consider the synergy. These interventions work together. Exercise alone slows epigenetic age, but exercise plus a good diet plus sleep quality may work better than any single factor. The trials that showed the largest effect used multiple interventions in parallel.
What the evidence does not yet show
It’s crucial to be clear about the limits of what we know. The epigenetic age trials are still small — the men’s RCT was 43 participants, the women’s data is six people. They haven’t yet run large, long-term trials in diverse populations. We don’t know if the epigenetic age reductions observed actually translate to lower cancer incidence in the real world. It’s biologically plausible, but not yet proven.
We also don’t know if these interventions work equally well for everyone, or which people benefit most. Age, sex, genetics, baseline health status — these might all modulate the response.
And the direction of causation remains unclear. Does slowing epigenetic age reduce cancer risk? Or do the lifestyle changes reduce cancer risk through other mechanisms, and the epigenetic age reduction is just a marker of those changes? Probably both, but we’ll need longer, larger trials to be sure.
The bottom line
Your biological age — measured through epigenetic markers — appears to be a meaningful predictor of cancer risk, independent of how many years you’ve lived. This is a relatively recent finding in the research, but it’s consistent across studies. Encouragingly, small-scale trials suggest that structured lifestyle changes — good nutrition, regular exercise, quality sleep, stress management — can slow epigenetic age, and in some cases reverse it. We can’t yet claim this reduces cancer risk directly, but the biology is plausible and the early data is promising.
If you’re looking for another reason to eat well, move regularly, sleep properly, and manage stress, consider this: you might be slowing your biological clock. And your cells might thank you for it.
References
- Dugué PA, et al. Association between biological age and cancer risk. International Journal of Cancer. 2017. DOI: 10.1002/ijc.31189.
- Chung JH, et al. Epigenetic age and stress-related biomarkers. Epigenetics. 2021. DOI: 10.1080/15592294.2020.1861401.
- Malyutina S, et al. Epigenetic age and biological dysfunction. International Journal of Molecular Sciences. 2024. DOI: 10.3390/ijms25094850.
- Fitzgerald KN, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention in overweight adults. Aging. 2021. DOI: 10.18632/aging.202913. [Note: 2024 correction published. DOI: 10.18632/aging.205700.]
- Fitzgerald KN, et al. Potential reversal of epigenetic age in women. Aging. 2023. DOI: 10.18632/aging.204602. [Preliminary case series; six participants.]
- Fiorito G, et al. DNA methylation-based biomarkers of aging were modified by a two-year multidomain intervention promoting healthy lifestyle. Aging Cell. 2021. DOI: 10.1111/acel.13439.
- Yaskolka Meir A, et al. Lifestyle intervention improves epigenetic age measures in adults with metabolic syndrome. Clinical Epigenetics. 2021. DOI: 10.1186/s13148-021-01038-0.
- Villanueva I, et al. Reversal of biological aging through multimodal intervention. Aging. 2025. DOI: 10.18632/aging.206240.
- Yaskolka Meir A, et al. Green-Mediterranean diet improves cardiovascular risk and epigenetic markers in adults with metabolic syndrome. BMC Medicine. 2023. DOI: 10.1186/s12916-023-03067-3.
This article is written for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, prevent, or cure any medical condition, including cancer. If you have a cancer diagnosis or are undergoing treatment, please discuss any lifestyle or dietary changes with your oncologist or medical team before making them. The studies cited reflect current research at the time of writing; the field is evolving rapidly and findings may be updated or superseded. Chloe Archard is a nutritional health coach, not a medical doctor.
